Difference between revisions of "Transformation of PL to AA"
(→Parameters) |
|||
Line 9: | Line 9: | ||
− | == Parameters == | + | == cPLA2a Parameters == |
Line 65: | Line 65: | ||
! Reference | ! Reference | ||
|- | |- | ||
− | |||
− | |||
|3600 | |3600 | ||
|<math> min{-1} </math> | |<math> min{-1} </math> |
Revision as of 13:19, 8 April 2016
Contents
Reaction
Chemical equation
Rate equation
cPLA2a Parameters
Value | Units | Species | Notes | Reference |
---|---|---|---|---|
2.60E+00 | Human | PMN | [1] | |
2.50E-03 | Mouse | Fibroblasts Cytosolic PLA2 | [2] | |
5.00E-02 | Human | Recombinant PLA2 (Phosphatidylcholine as the substrate) | [3] | |
2.00E-02 | Human | Recombinant PLA2 (Phosphatidylethanolamine as the substrate) | [3] | |
4.13E-01 ± 2.80E-02 | Rat | PMN Neutrophils | [4] |
Enzyme | E.C. | Value | Units | Species | Notes | Reference |
---|---|---|---|---|---|---|
3600 | Failed to parse (Cannot store math image on filesystem.): min{-1} | Human | PMN | [1] |
References
- ↑ 1.0 1.1 Yang K. “Finding multiple target optimal intervention in disease-related molecular network.” Mol Syst Biol 2008, (4):228
- ↑ Spaargaren M. “Characterization and identification of an epidermal-growth-factor-activated phospholipase A2.” Biochem J. 1992 Oct 1; 287(Pt 1): 37–43.
- ↑ 3.0 3.1 Kawauchi Y. “Preparation and characterization of human rheumatoid arthritic synovial fluid phospholipase A2 produced by recombinant baculovirus-infected insect cells.” J Biochem. 1994 Jul;116(1):81-7.
- ↑ Kawauchi Y. “Changes in kinetic properties of cytosolic phospholipase A2 in activated rat neutrophils.” Adv Exp Med Biol. 1997;433:439-42.